First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Sees Strong Trading Volume – Should You Buy?

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) shares saw unusually-strong trading volume on Tuesday . Approximately 380,568 shares changed hands during mid-day trading, an increase of 57% from the previous session’s volume of 241,641 shares.The stock last traded at $38.58 and had previously closed at $38.59.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 0.7%

The stock has a market cap of $925.04 million, a price-to-earnings ratio of 14.51 and a beta of 0.45. The stock’s 50 day moving average is $37.38 and its two-hundred day moving average is $35.37.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Thursday, June 25th were given a $0.092 dividend. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.06. The ex-dividend date was Thursday, June 25th. This represents a $0.37 annualized dividend and a yield of 0.9%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of FTXH. NBC Securities Inc. raised its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 33.0% during the fourth quarter. NBC Securities Inc. now owns 1,325 shares of the company’s stock worth $44,000 after purchasing an additional 329 shares during the last quarter. Raymond James Financial Inc. purchased a new position in First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter worth $57,000. Kestra Advisory Services LLC acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF in the 4th quarter worth $59,000. Flagship Harbor Advisors LLC acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF in the 4th quarter worth $205,000. Finally, Flputnam Investment Management Co. purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF in the fourth quarter valued at about $230,000.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.